Table 4.
Correlation between fibrinogen levels and the probability of favorable outcomes
| Predictors | OR (95% CI) | P valuea |
|---|---|---|
| 3-month favorable outcome for patients with fibrinogen level < 2.5 g/L | ||
| AGE | 0.965 (0.955–0.975) | < .001 |
| GCS | 1.624 (1.539–1.714) | < .001 |
| SDH | 0.601 (0.440–0.821) | .001 |
| EDH | 1.615 (1.124–2.321) | .010 |
| IPH or brain contusion | 0.448 (0.302–0.665) | < .001 |
| D-dimer | 0.975 (0.964–0.986) | < .001 |
| FIB | 1.654 (1.186–2.306) | .003 |
| Thorax injury | 0.509 (0.277–0.934) | .029 |
| 3-month favorable outcome for patients with fibrinogen level > 3.0 g/L | ||
| Predictors | OR (95% CI) | P valuea |
| GCS | 1.555 (1.450–1.668) | < .001 |
| IPH or brain contusion | 0.446 (0.246–0.808) | .008 |
| D-dimer | 0.932 (0.899–0.966) | < .001 |
| FIB | 0.771 (0.607–0.979) | .033 |
GCS Glasgow Coma Scale, FIB fibrinogen, EDH epidural hematoma, SDH subdural hematoma, IPH intraparenchymal hemorrhage
aP values adjusted for multiple comparisons. Statistical significance determined by multiple logistic regression analysis